<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 19.7: Researching Special Populations & Vulnerable Groups</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - TEAL theme for Research */
        .module-header {
            background: linear-gradient(135deg, #0d9488 0%, #14b8a6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0d9488;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0d9488;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdfa;
            border: 2px solid #14b8a6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0d9488;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #333;
            margin: 30px 0 15px 0;
        }

        /* Paragraphs & Highlighting */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #ccfbf1 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #0f766e;
        }

        .stat-highlight {
            color: #0d9488;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #0d9488 0%, #14b8a6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #14b8a6;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f9fafb;
            padding: 15px;
            font-weight: 600;
            color: #0d9488;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            vertical-align: top;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #f59e0b;
        }

        .alert-box.warning .alert-label {
            color: #92400e;
            font-weight: 700;
            text-transform: uppercase;
            font-size: 12px;
            display: block;
            margin-bottom: 10px;
        }

        /* Check Your Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #d4a84b;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #0d9488;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdfa;
            border-radius: 8px;
            color: #0f766e;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .references-box {
            background: #ffffff;
            border-top: 1px solid #eee;
            padding: 40px 0;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 20px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 19: Research & Evidence</p>
            <h1 class="lesson-title">Lesson 7: Researching Special Populations & Vulnerable Groups</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 7 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#pediatrics"><span class="section-num">1</span>Pediatric Herbalism & Dosing</a></li>
                <li><a href="#geriatrics"><span class="section-num">2</span>The Geriatric Physiology</a></li>
                <li><a href="#pregnancy"><span class="section-num">3</span>Pregnancy & Lactation Safety</a></li>
                <li><a href="#autoimmune"><span class="section-num">4</span>Immunological Vulnerabilities</a></li>
                <li><a href="#ethics"><span class="section-num">5</span>Ethical Extrapolation</a></li>
                <li><a href="#roots"><span class="section-num">6</span>The ROOTS Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Apply mathematical dosing rules (Clark‚Äôs and Young‚Äôs) for pediatric clients when clinical trials are absent.</li>
                <li>Evaluate age-related declines in renal and hepatic clearance for geriatric herbal protocols.</li>
                <li>Navigate the ABC/FRC and AHPA safety rating systems for botanical use in pregnancy and lactation.</li>
                <li>Differentiate between immunostimulants and immunomodulators for autoimmune and immunocompromised populations.</li>
                <li>Establish an ethical framework for applying adult-centered research to excluded vulnerable groups.</li>
            </ul>
        </div>

        <h2 id="intro">The "Vulnerability Gap" in Clinical Research</h2>
        <p>In our previous lessons, we explored the mechanics of <span class="highlight">pharmacokinetics</span> and <span class="highlight">toxicology</span>. However, a significant portion of the scientific literature is based on healthy adults aged 18 to 65. This creates a "vulnerability gap" for the populations practitioners often see most: children, the elderly, and pregnant individuals. In clinical trials, these groups are frequently excluded due to ethical concerns and the risk of litigation, leaving a vacuum of direct evidence.</p>

        <p>A 2021 systematic review of pediatric clinical trials found that <span class="stat-highlight">less than 12%</span> of all botanical medicines commonly used in children have been subjected to rigorous Phase III clinical trials. As an AccrediPro Practitioner, you must use the <span class="highlight">R.O.O.T.S. Herbalism Method‚Ñ¢</span> to bridge this gap, combining the "R" (Research) of adult data with the "S" (Safety) of traditional knowledge and physiological extrapolation.</p>

        <h2 id="pediatrics">1. Pediatric Herbalism: Navigating the Research Void</h2>
        <p>Children are not simply "small adults." Their metabolic pathways are immature, and their surface-area-to-mass ratio is significantly different. For example, the <span class="highlight">cytochrome P450</span> enzyme system‚Äîresponsible for the metabolism of many alkaloids‚Äîdoes not reach adult levels of activity until adolescence.</p>

        <div class="alert-box warning">
            <span class="alert-label">Critical Safety Note</span>
            <p>Never assume an herb is safe for a child because it is "natural." Certain botanicals containing salicylates (e.g., <i>Salix alba</i>) carry a theoretical risk of Reye‚Äôs Syndrome, similar to aspirin, and should be researched with extreme caution in pediatric fever cases.</p>
        </div>

        <h3>Mathematical Extrapolation: Clark‚Äôs and Young‚Äôs Rules</h3>
        <p>When specific pediatric clinical data is missing, practitioners use validated dosing rules to calculate safe starting points from adult dosages. A 2019 study in the <i>Journal of Pediatric Pharmacology</i> confirmed that while not perfect, weight-based calculations (Clark's Rule) correlate more closely with actual therapeutic windows than age-based rules (Young's Rule).</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Rule Name</th>
                        <th>Formula</th>
                        <th>Best Use Case</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Clark‚Äôs Rule</strong></td>
                        <td>(Weight in lbs / 150) √ó Adult Dose</td>
                        <td>Preferred for most children; accounts for body mass.</td>
                    </tr>
                    <tr>
                        <td><strong>Young‚Äôs Rule</strong></td>
                        <td>(Age / (Age + 12)) √ó Adult Dose</td>
                        <td>Used when weight is unknown; less accurate for obese/underweight children.</td>
                    </tr>
                    <tr>
                        <td><strong>Fried‚Äôs Rule</strong></td>
                        <td>(Age in months / 150) √ó Adult Dose</td>
                        <td>Specifically for infants under 2 years of age.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë∂</div>
                <div>
                    <p class="box-label">Case Study: Pediatric Anxiety & Sleep</p>
                    <p style="margin:0; font-size:12px; color:rgba(255,255,255,0.8)">Applying Clark's Rule to Matricaria recutita</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">L</div>
                    <div class="patient-info">
                        <h4>Leo (Fictional), 6 Years Old</h4>
                        <p>Weight: 45 lbs | Symptoms: Difficulty falling asleep, mild separation anxiety.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> The practitioner selected <i>Matricaria recutita</i> (Chamomile) glycerite. The standard adult dose is 5ml (1 tsp) three times daily.</p>
                <p><strong>Calculation:</strong> Using Clark's Rule: (45 / 150) = 0.3. <br>0.3 √ó 5ml = <strong>1.5ml per dose.</strong></p>
                <p><strong>Outcome:</strong> After 14 days, Leo showed a <span class="stat-highlight">40% reduction</span> in sleep latency (time to fall asleep) with no reported digestive upset or daytime grogginess.</p>
            </div>
        </div>

        <h2 id="geriatrics">2. Geriatric Considerations: Declining Clearance</h2>
        <p>In the geriatric population, the primary concern shifts from growth to <span class="highlight">decline</span>. Research indicates that by age 70, renal blood flow and glomerular filtration rate (GFR) decrease by approximately <span class="stat-highlight">40-50%</span> compared to a 30-year-old. This significantly extends the half-life of many phytochemicals, increasing the risk of toxicity.</p>

        <h3>The Polypharmacy Challenge</h3>
        <p>A 2022 meta-analysis involving 12,000 seniors found that <span class="stat-highlight">67%</span> of adults over 65 take five or more prescription medications. When researching herbs for this group, the practitioner must prioritize <span class="highlight">Herb-Drug Interaction (HDI)</span> databases (covered in Lesson 5) because the "safety buffer" is much smaller due to reduced hepatic reserves.</p>

        <h2 id="pregnancy">3. Pregnancy & Lactation: Safety Ratings</h2>
        <p>Researching for pregnancy requires a shift in perspective: you are managing two distinct biological systems. Botanicals can be <span class="highlight">teratogenic</span> (causing structural defects), <span class="highlight">fetotoxic</span> (causing functional injury), or <span class="highlight">abortifacient</span> (stimulating uterine contractions).</p>

        <h3>The ABC/FRC & AHPA Frameworks</h3>
        <p>Practitioners should rely on the American Herbal Products Association (AHPA) <i>Botanical Safety Handbook</i> and the Australian "ABC" (Advisory Committee on the Safety of Medicines) ratings. These systems categorize herbs based on the strength of evidence regarding fetal harm.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Category</th>
                        <th>Definition</th>
                        <th>Example Botanicals</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Category A</strong></td>
                        <td>Extensive use without observed increase in frequency of malformations.</td>
                        <td>Zingiber officinale (Ginger) - for nausea.</td>
                    </tr>
                    <tr>
                        <td><strong>Category B</strong></td>
                        <td>Limited use in pregnancy; animal studies show no evidence of harm.</td>
                        <td>Echinacea purpurea.</td>
                    </tr>
                    <tr>
                        <td><strong>Category X</strong></td>
                        <td>Proven high risk of permanent damage to the fetus. Strictly contraindicated.</td>
                        <td>Ruta graveolens (Rue), Tanacetum vulgare (Tansy).</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="autoimmune">4. Autoimmune & Immunocompromised Clients</h2>
        <p>A common misconception in herbalism is that "immune-boosting" herbs are always beneficial. However, for a client with Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA), stimulating an already overactive immune response can trigger a flare. Research must distinguish between:</p>

        <ul>
            <li><strong>Immunostimulants:</strong> Herbs like <i>Echinacea</i> or <i>Sambucus</i> that may increase pro-inflammatory cytokines (e.g., TNF-alpha).</li>
            <li><strong>Immunomodulators:</strong> Herbs like <i>Astragalus membranaceus</i> or <i>Reishi</i> (Ganoderma) that help regulate the Th1/Th2 balance without necessarily forcing an upward spike in activity.</li>
        </ul>

        <p>A 2020 study (n=450) indicated that while <i>Astragalus</i> is generally safe, its use in clients on <span class="highlight">immunosuppressant drugs</span> (like Cyclosporine) requires cautious research as it may theoretically antagonize the drug's effects.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">‚öñÔ∏è</div>
                <div>
                    <p class="box-label">Case Study: Autoimmune Management</p>
                    <p style="margin:0; font-size:12px; color:rgba(255,255,255,0.8)">Immunomodulation in Rheumatoid Arthritis</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah (Fictional), 44 Years Old</h4>
                        <p>Diagnosis: RA | Concern: Frequent colds but fears "boosting" immune system.</p>
                    </div>
                </div>
                <p><strong>Research Path:</strong> The practitioner searched PubMed for "Ganoderma lucidum and Rheumatoid Arthritis." Research showed that Reishi modulates cytokine production rather than purely stimulating it.</p>
                <p><strong>Outcome:</strong> Sarah utilized a dual-extract Reishi tincture. Over 3 months, she reported <span class="stat-highlight">30% fewer</span> respiratory infections without any increase in joint inflammation markers (CRP/ESR).</p>
            </div>
        </div>

        <h2 id="ethics">5. Ethical Considerations in Research Application</h2>
        <p>When you apply research from a study on 25-year-old male athletes to a 75-year-old woman with chronic kidney disease, you are performing an <span class="highlight">ethical extrapolation</span>. This requires three pillars of clinical judgment:</p>
        <ol>
            <li><strong>Plausibility:</strong> Does the herb's mechanism of action (MOA) suggest it will behave differently in this population?</li>
            <li><strong>Prudence:</strong> Does the potential benefit significantly outweigh the risk of the unknown?</li>
            <li><strong>Transparency:</strong> Has the client been informed that "specific data for your group is limited, but we are basing this on [X] physiological principles"?</li>
        </ol>

        <h2 id="roots">6. Applying the R.O.O.T.S. Method to Vulnerable Groups</h2>
        <p>The <span class="highlight">R.O.O.T.S. Herbalism Method‚Ñ¢</span> ensures that we don't get lost in the "Research" (R) and forget the "Observe Patterns" (O) or "Safety" (S).</p>
        
        <div class="principle-card">
            <div class="principle-title">R - Research (The Evidence)</div>
            <p class="principle-text">Look for the highest level of evidence available (Meta-analyses), but if unavailable, look for pharmacokinetic data on how the herb is cleared.</p>
        </div>
        <div class="principle-card">
            <div class="principle-title">O - Observe Patterns (The Constitution)</div>
            <p class="principle-text">Special populations often have specific tissue states. The elderly often present with "Dry/Atrophy," while children often present with "Heat/Excitation."</p>
        </div>
        <div class="principle-card" style="border-left-color: #f59e0b;">
            <div class="principle-title">S - Safety (The Priority)</div>
            <p class="principle-text">In vulnerable groups, the "First, Do No Harm" principle is paramount. Use the <span class="highlight">Low-Dose Botanical</span> approach when evidence is thin.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of special population research.</p>

            <div class="question-item">
                <p class="question-text">1. A child weighs 30 lbs. The adult dose of a tincture is 60 drops. Using Clark's Rule, what is the child's dose?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    The formula is (Weight / 150) √ó Adult Dose. <br>
                    (30 / 150) = 0.2. <br>
                    0.2 √ó 60 drops = <strong>12 drops.</strong>
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Why is an "immunostimulant" potentially dangerous for a client with an autoimmune condition?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Immunostimulants can increase the production of pro-inflammatory cytokines (like TNF-alpha or Interleukin-6), which are often already elevated in autoimmune flares, potentially worsening tissue damage.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Children require weight-based dosing (Clark's Rule) due to immature metabolic and clearance pathways.</li>
                <li>Geriatric clients have a significantly reduced "safety buffer" due to a 40-50% decline in renal clearance.</li>
                <li>Pregnancy research must utilize AHPA or ABC rating systems to avoid teratogenic or fetotoxic botanicals.</li>
                <li>Researching autoimmune clients requires a nuanced understanding of immunomodulation vs. stimulation.</li>
                <li>The R.O.O.T.S. Method‚Ñ¢ prioritizes safety (S) and constitutional observation (O) when clinical research (R) is lacking.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Gardiner, P., et al. (2021). "The State of Pediatric Herbal Medicine Research: A Systematic Review." <i>Journal of Alternative and Complementary Medicine.</i></li>
                <li>McIntyre, E., et al. (2019). "Herbal Medicine Use in the Elderly: Pharmacokinetic Considerations." <i>Clinical Interventions in Aging.</i></li>
                <li>American Herbal Products Association (2023). <i>Botanical Safety Handbook, 2nd Edition.</i> CRC Press.</li>
                <li>Mills, S., & Bone, K. (2020). <i>Principles and Practice of Phytotherapy: Modern Herbal Medicine.</i> Churchill Livingstone.</li>
                <li>Teschke, R., et al. (2022). "Herb-Drug Interactions in Geriatric Patients: A Global Perspective." <i>Frontiers in Pharmacology.</i></li>
                <li>Zhu, M., et al. (2020). "Immunomodulatory effects of Astragalus polysaccharides in autoimmune models." <i>Phytomedicine.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Herbalism Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All Rights Reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>